Who owns the ORMALVI trademark?

The ORMALVI trademark is owned by Torrent Pharma Inc..

What class is the ORMALVI trademark registered in?

The ORMALVI trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ORMALVI?

The USPTO serial number for ORMALVI is 98300051.

What is the registration number for ORMALVI?

ORMALVI is registered under USPTO registration number 7951200.

Sealvo

Home Search: ORMALVIORMALVI #98300051

Back

Updated Oct 8, 2026·37 searches this week

View on USPTO TSDR Find similar marks

ORM

USPTO Trademark Record

REGISTERED

ORMALVI

SN 98300051·Reg 7951200·Filed Dec 05, 2023

Owner Torrent Pharma Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ORMALVI (Serial No. 98300051), Registration No. 7951200, is a registered US trademark filed on Dec 05, 2023 by Torrent Pharma Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: September 16, 2031

Mark Intelligence

ORMALVI (Reg. #7951200) is a registered US trademark that has been protecting its owner, Torrent Pharma Inc., since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 05, 2023

SERIAL

98300051

REG#

7951200

REGISTERED

Sep 16, 2025

Filing Information

StatusREGISTERED

Filing DateDec 05, 2023

Serial Number98300051

Registration No.7951200

Registration DateSep 16, 2025

Status DateSep 16, 2025

Published for OppositionDec 17, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Apr 15, 2024

First use in commerce: Apr 15, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

48 events

REGISTERED-PRINCIPAL REGISTER

Sep 16, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 16, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 27, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 27, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 25, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO LIE

Aug 25, 2025

ASSIGNED TO LIE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 25, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Aug 25, 2025

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 12, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

May 12, 2025

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

May 12, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 12, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

May 09, 2025

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 09, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Feb 19, 2025

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Feb 19, 2025

TEAS STATEMENT OF USE RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Feb 18, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Feb 18, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 18, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Feb 18, 2025

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 11, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 17, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Dec 17, 2024

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 11, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Oct 15, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Oct 15, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 15, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Oct 15, 2024

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 15, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Oct 11, 2024

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 11, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 11, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

FINAL REFUSAL WRITTEN

Aug 30, 2024

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Aug 30, 2024

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Aug 30, 2024

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 05, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 05, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 05, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 05, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 05, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 05, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO EXAMINER

Jul 03, 2024

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Jul 03, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 03, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 03, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS VOLUNTARY AMENDMENT RECEIVED

May 29, 2024

TEAS VOLUNTARY AMENDMENT RECEIVED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 01, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 05, 2023

NEW APPLICATION ENTERED

Other Marks by Torrent Pharma Inc.

Additional USPTO filings from the same owner.

VEN

VENXXIVA

98571152

Torrent Pharma Inc.

REGISTERED

PAZ

PAZTELKI

99410519

Torrent Pharma Inc.

PENDING

SIM

SIMDOFA

99410525

Torrent Pharma Inc.

PENDING

Other Marks by John P. Olson

Additional USPTO filings handled by the same attorney of record.

LOG

LogoMark

99412703

REGISTERED

HAN

HANEN LAUNCHPAD TO LITERACY

79436951

REGISTERED

PER

PERAGON

88245835

REGISTERED

BES

BE.SMART

79411749

REGISTERED

ORMALVI

Run a conflict check

Other Marks by Torrent Pharma Inc.

Other Marks by John P. Olson

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company